Recent Updates
Recently added Catalysts
DMAC Positive Sentiment Score: 70/100

DiaMedica Therapeutics to Present at the 2019 Intellisight Investor Conference on August 14, 2019

Monday, August 12, 2019 1 min read
Key Takeaway: DiaMedica Therapeutics Inc. will present at the 2019 Intellisight Conference on August 14. CEO Rick Pauls will discuss the company's focus on chronic kidney diseases and neurological disorders. DiaMedica is currently conducting a phase II study in acute ischemic stroke and a phase Ib study in chronic kidney disease.

Market Sentiment Analysis

POSITIVE FACTORS

  • DiaMedica Therapeutics is actively engaging with investors.
  • The company is focused on developing innovative treatments.
  • Ongoing clinical studies indicate progress in their research.

Full Press Release Details

MINNEAPOLIS, Aug. 12, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that Rick Pauls, President and CEO, will be presenting at the 2019 Intellisight Conference, Wednesday, August 14that 9:00 am Central Time at University of St. Thomas in Minneapolis, Minnesota.

About Intellisight

Intellisight is a 2-day conference sponsored by the University of St. Thomas – School of Law for institutional investors to meet with leadership teams from numerous companies, and for company leadership to meet with influential investors representing more than 200 buy-side firms.

About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney diseases and neurological disorders. The Company currently has an ongoing phase II study in acute ischemic stroke and a phase Ib study in chronic kidney disease. DiaMedica’s shares are listed on The Nasdaq Capital Market under the trading symbol “DMAC.”

For more information, please visitwww.diamedica.com.Contact:

Scott KellenChief Financial OfficerPhone: (763) 496-5118skellen@diamedica.com

Frequently Asked Questions

When will DiaMedica present at the Intellisight Conference?

DiaMedica will present on August 14, 2019, at 9:00 am Central Time.

Who is presenting for DiaMedica at the conference?

Rick Pauls, the President and CEO, will be presenting.

What is the focus of DiaMedica's research?

DiaMedica focuses on developing treatments for chronic kidney diseases and neurological disorders.

Where is the Intellisight Conference held?

The conference is held at the University of St. Thomas in Minneapolis, Minnesota.

Tags: DMAC Viatris Investor Conferences Healthcare DiaMedica Therapeutics Intellisight Conference chronic kidney disease acute ischemic stroke
Last updated: Aug 12, 2019